ID   IMR-32rMEL500
AC   CVCL_RR71
DR   Wikidata; Q54897637
RX   PubMed=24466371;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
RX   PubMed=24466371; DOI=10.1593/tlo.13544; PMCID=PMC3890703;
RA   Loschmann, Nadine
RA   Michaelis, Martin
RA   Rothweiler, Florian
RA   Zehner, Richard
RA   Cinatl, Jaroslaw
RA   Voges, Yvonne
RA   Sharifi, Mohsen
RA   Riecken, Kristoffer
RA   Meyer, Jochen
RA   von Deimling, Andreas
RA   Fichtner, Iduna
RA   Ghafourian, Taravat
RA   Westermann, Frank
RA   Cinatl, Jindrich Jr.
RT   "Testing of SNS-032 in a panel of human neuroblastoma cell lines with
RT   acquired resistance to a broad range of drugs.";
RL   Transl. Oncol. 6:685-696(2013).
//
RX   PubMed=31581737; DOI=10.3390/cells8101194; PMCID=PMC6830094;
RA   Povey, Jane F.
RA   Saintas, Emily
RA   Aderemi, Adewale Victor
RA   Rothweiler, Florian
RA   Zehner, Richard
RA   Dirks, Wilhelm Gerhard
RA   Cinatl, Jindrich Jr.
RA   Racher, Andrew J.
RA   Wass, Mark N.
RA   Smales, Christopher Mark
RA   Michaelis, Martin
RT   "Intact-cell MALDI-ToF mass spectrometry for the authentication of
RT   drug-adapted cancer cell lines.";
RL   Cells 8:1194.1-1194.12(2019).
//